V014-0626 Screening compound: N-{3-[2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-1H-indol-5-yl}hexadecanamide

V014-0626 Screening compound: N-{3-[2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-1H-indol-5-yl}hexadecanamide
V014-0626 Screening compound: N-{3-[2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-1H-indol-5-yl}hexadecanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V014-0626
N-{3-[2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-1H-indol-5-yl}hexadecanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V014-0626

Molecular Formula

C35H51N3O (C35 H51 N3 O)

Compound Name

N-{3-[2-(1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]-1H-indol-5-yl}hexadecanamide

IUPAC name

N-{3-[2-(1234-tetrahydroisoquinolin-2-yl)ethyl]-1H-indol-5-yl}hexadecanamide

SMILES

CCCCCCCCCCCCCCCC(Nc(cc1)cc2c1[nH]cc2CCN(CC1)Cc2c1cccc2)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

529.81

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

19.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

10.080

Distribution Coefficient, logD

9.473

Water Solubility, LogSw

-5.73

Polar Surface Area

36.631

Acid Dissociation Constant (pKa)

11.84

Base Dissociation Constant (pKb)

7.88

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.10

V014-0626 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Indole Derivatives (10091 compounds)

Lipid Metabolism Library (9174 compounds)

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with V014-0626 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V014-0626?
Check Price and Availability of V014-0626, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V014-0626 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V014-0626
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V014-0626
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V014-0626 available by request